WallStreetZenWallStreetZen

AnalystsCatherine Schulte
Catherine Schulte's Stock Forecasts

Analyst Ranking
Top 3%
#97 out of 4174 analysts
Average Return
+29.97%
Win Rate
79%30 out of 38
Risk vs Reward
Poor
Good

Catherine Schulte's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nanostring Technologies IncNSTG
+172.99%$25.14$68.63
2020-04-06 -
2021-04-07
Buy
Exact Sciences CorpEXAS
+117.49%$44.37$96.50
2018-02-26 -
2019-02-27
Buy
Castle Biosciences IncCSTL
+112.13%$28.27$59.97
2020-03-26 -
2021-03-26
Buy
Nanostring Technologies IncNSTG
+106.07%$14.00$28.85
2018-06-03 -
2019-06-04
Buy
Nanostring Technologies IncNSTG
+96.15%$7.79$15.28
2017-11-02 -
2018-11-02
Buy

Catherine Schulte Analyst Color

Get additional color on Catherine Schulte's coverage of popular stocks

Catherine Schulte's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Avantor IncAVTR
4Buy$27.00+15.29%Maintains
2 days ago
Danaher CorpDHR
2Buy$321.00+21.71%Maintains
15 days ago
Twist Bioscience CorpTWST
2Buy$33.00+39.06%Maintains
3 months ago
Castle Biosciences IncCSTL
3Buy$41.00+53.50%Maintains
3 months ago
Perkinelmer IncPKI
3Buy$202.00+46.48%Maintains
6 months ago
Mettler Toledo International IncMTD
1Hold$1,406.00-9.64%Maintains
6 months ago
Biora Therapeutics IncBIOR
1Hold$2.00N/ADowngrades
2 years ago
Chembio Diagnostics IncCEMI
1Buy$21.00N/AInitiates Coverage On
3 years ago
Illumina IncILMN
4Hold$310.00N/ADowngrades
3 years ago
Nanostring Technologies IncNSTG
5Buy$29.00N/AMaintains
3 years ago
Thermo Fisher Scientific IncTMO
2Buy$288.00N/AMaintains
4 years ago
Waters CorpWAT
5Hold$211.00N/ADowngrades
4 years ago
Exact Sciences CorpEXAS
7Buy$85.00N/AMaintains
4 years ago
Natera IncNTRA
1Buy$20.00N/AMaintains
5 years ago
Bio Techne CorpTECH
1Buy$157.00N/AMaintains
5 years ago
Agilent Technologies IncA
1Buy$70.00N/AMaintains
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.